Semaglutide initiation caused lithium toxicity in patients on lithium therapy due to altered renal clearance, highlighting a critical drug interaction for psychiatric patients.
Key findingSemaglutide initiation caused lithium toxicity in patients on lithium therapy due to altered renal c
What the researchers found
Semaglutide initiation caused lithium toxicity in patients on lithium therapy due to altered renal clearance, highlighting a critical drug interaction for psychiatric patients.
Why it matters
This finding has implications for the millions of patients using or considering peptide-based therapies.
The numbers in context
3 patients on stable lithium developed toxicity after semaglutide initiation. Lithium has a narrow therapeutic index requiring careful monitoring.
How the study worked
Clinical or preclinical study with methodology detailed in the full publication.
Who was studied
Adults with bipolar disorder on stable lithium regimens who started semaglutide
What this study cannot tell us
Study-specific limitations are discussed in the full publication. As with all research, findings should be interpreted in the context of study design and population.
How to read the evidence
Evidence grade assessment based on study design and methodology detailed in the full publication.
When this study was published
Published in 2025. Reflects current state of peptide therapeutic research.
The bigger picture
This study adds to the rapidly expanding evidence base for peptide-based therapeutics across multiple medical specialties.
Questions still open
- What are the long-term implications of these findings?
- How do these results compare to other studies in this area?
- What further research is needed to confirm and extend these findings?
Common questions
What does this study mean for patients?
How reliable are these findings?
Read the original research
Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review.
Journal of clinical psychopharmacology, 45(6), 613-618
Citation
Al-Soleiti, Majd; Leung, Jonathan G; Mubaydeen, Teeba; Markota, Matej; Abulseoud, Osama; Singh, Balwinder; Sola, Christopher L. (2025). Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review.. Journal of clinical psychopharmacology, 45(6), 613-618. https://doi.org/10.1097/JCP.0000000000002090